An Empirical Analysis of Director Mingjun Zhao’s Experience in Treating Chronic Heart Failure

With the aggravation of an aging population,the prevalence of chronic heart failure is increasing.As a famous traditional Chinese medicine practitioner in Shaanxi Province,Mingjun Zhao is amicable at using traditional Chinese medicine to treat chronic heart failure.He believes that the pathogenesis of the condition is mainly due to the lack of heart Yang,deficiency of heart Qi,as well as the combination of water and blood stasis.Therefore,in treating this condition,it is essential to warm and nourish heart Yang,replenish Qi to benefit water,and promote blood circulation to remove blood stasis.Based on the standardized treatment used in western medicine,traditional Chinese medicine should be reasonably and accurately combined with it as a drug pair into a prescription,thus highlighting the advantages of the combination of traditional Chinese medicine in the treatment of chronic heart failure to a great extent.

Research Progress of Traditional Chinese and Western Medicine in Hyperthyroid Heart Disease

In recent years,hyperthyroid heart disease has become a condition with high incidence rate and high mortality rate.This paper discusses the pathogenesis,treatment,and influencing factors of hyperthyroid heart disease from two different angles-traditional Chinese medicine and western medicine-in hope to provide a reference basis for the treatment of hyperthyroid heart disease.

On the Modern Clinical Application of Wendan Decoction

Wendan Decoction is one of the commonly used prescriptions in clinical practice.it has a wide range of applications.On the basis of traditional Chinese medicine(TCM)syndrome differentiation,as long as it can be added or subdivided flexibly,it can be used to conquer various difficult and miscellaneous diseases seen in daily life.

Progress of TCM Syndrome Differentiation and Treatment of Hypertension with Sleep Disorders

It has been discovered that the number of hypertensive patients with various types of sleep disorders is on the rise,which significantly increases the morbidity and mortality of cardiovascular diseases.Modern medicine has not reached a consensus on the mechanism and treatment of these diseases but relies on drugs to improve sleep disorders and blood pressure.We regard TCM syndrome differentiation as the breakthrough point,along with comprehensive modern and traditional medical methods based on dialectical thinking as means of holistic and symptomatic treatment of Western medicine integrated with the eight principles of TCM diagnosis,Zang-Fu organs,six meridians,Qi,blood and fluid,as well as other dialectical methods,in order to provide a broader idea for TCM treatment and lay a foundation for further and better development of integrated TCM and Western medicine treatment.

Discussion on the Mechanism of Action of High-frequency Drugs for Treating Heart Failure Based on Network Pharmacology

Objective:To explore the target and mechanism of Astragalus membranaceus,poria,salvia miltiorrhiza and semen leiocarpa in the treatment of heart failure by network pharmacology.Methods:The active components of traditional Chinese medicine and the target of heart failure were screened by multi-platform,and the standard gene was transformed by Uniprot.CytoCasp 3.6.1 was used to draw the network diagram of traditional Chinese medicine・component-target.Go and KEGG analysis were performed by Metascape.Results:A total of 36 predictive target sites of Radix Astragalus,Fuling poria,Salvia miltiorrhiza and Draba nemorosa were screened for treatment of heart failure,mainly involving nerve and factor pathways:ADRB2,ADRA1B and AChE.Cancer pathway:TP53,TNF;Pathways of inflammation:IL1B,PTSG2,PTSG1;Sex hormone pathway:ESRI,AR,PGR;Others:SCN5A,HIF1A,etc.The results of GO and KEGG enrichment suggested that the treatment of heart failure with the top four drugs involved cancer pathway,calcium signaling pathway,HIF-1 signaling pathway,and involved in blood circulation,cell proliferation and other processes.Conclusion:This study combines the pharmacological studies of Chinese medicine and western medicine to reveal the mechanism of multi-target and multi-channel regulation of body balance in Chinese medicine treatment.

中国大型真菌受威胁物种名录

为全面评估中国大型真菌受威胁状况,原环境保护部联合中国科学院于2016年启动了《中国生物多样性红色名录--大型真菌卷》的编制工作。本次评估过程中制定了中国大型真菌红色名录评估等级与标准(王科等, 2020),并依此开展评估工作。使用了以下评估等级:灭绝(Extinct, EX)、野外灭绝(Extinct in the Wild, EW)、疑似灭绝(Possibly Extinct,PE)、极危(CriticallyEndangered,CR)、濒危(Endangered,EN)、易危(Vulnerable,VU)、近危(Near Threatened, NT)、无危(Least Concern, LC)和数据不足(Data Deficient, DD)。

中国菌物名录数据库在大型真菌红色名录编制中的作用

长期以来,分类学的研究成果主要以平面的方式发表在各种纸质文献资料中。近年来,随着计算机和人工智能等新兴技术的发展和应用,平面资料信息的数字化成为一种趋势,世界各国都非常重视本国生物资源信息的收集汇总,构建了多种数据库,为科学研究、政府决策、资源保护、合理利用和科学传播提供了重要的信息基础。本研究探索并建立从菌物学平面资料信息构建数据库的流程和方法,并在中国菌物名录数据库和IndexFungorum所收集数据的基础上进行数据挖掘和分析。通过软件操作和程序设计,在数据库中提取相关信息,辅助完成了《中国生物多样性红色名录--大型真菌卷》的编制工作,同时梳理和规范了菌物拉丁和汉语学名,为菌物分类研究和资源评估与保护提供基础。